Genomic regulatory sequences in the pathogenesis of bipolar disorder

Frontiers in Psychiatry

Psychiatry

Anastasia Levchenko¹  Maria Plotnikova² 

[1]Institute of Translational Biomedicine, Saint Petersburg State University, Saint Petersburg, Russia

[2]Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow, Russia

[3]Center for Genetics and Life Science, Sirius University of Science and Technology, Sochi, Russia

关键词: bipolar disorder;    genome-wide association study (GWAS);    epigenetics;    transcription;    functional genetic variant;    RNA;   

DOI  :  10.3389/fpsyt.2023.1115924

 received in 2022-12-04, accepted in 2023-01-23,  发布年份 2023

来源: Frontiers

【 摘 要 】

The lifetime prevalence of bipolar disorder is estimated to be about 2%. Epigenetics defines regulatory mechanisms that determine relatively stable patterns of gene expression by controlling all key steps, from DNA to messenger RNA to protein. This Mini Review highlights recent discoveries of modified epigenetic control resulting from genetic variants associated with bipolar disorder in genome-wide association studies. The revealed epigenetic abnormalities implicate gene transcription and post-transcriptional regulation. In the light of these discoveries, the Mini Review focuses on the genes PACS1, MCHR1, DCLK3, HAPLN4, LMAN2L, TMEM258, GNL3, LRRC57, CACNA1C, CACNA1D, and NOVA2 and their potential biological role in the pathogenesis of bipolar disorder. Molecular mechanisms under control of these genes do not translate into a unified picture and substantially more research is needed to fill the gaps in knowledge and to solve current limitations in prognosis and treatment of bipolar disorder. In conclusion, the genetic and functional studies confirm the complex nature of bipolar disorder and indicate future research directions to explore possible targeted treatment options, eventually working toward a personalized approach.

【 授权许可】

Unknown   
Copyright © 2023 Levchenko and Plotnikova.